CD8A and neoplasm: Moreover, some researchers have found that the levels of immune cell infiltration, including the distribution of CD8+ T cells in the tumor microenvironment, can predict the clinical efficacy of PD1 inhibitors more accurately than the expression of PD1 or PD-L1 or TMB [28].